↓ Skip to main content

Dove Medical Press

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, September 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#48 of 1,196)
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
5 news outlets
blogs
1 blog
twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
95 Mendeley
Title
Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
Published in
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, September 2017
DOI 10.2147/dmso.s141235
Pubmed ID
Authors

Mirko V Sikirica, Alan A Martin, Robert Wood, Andrea Leith, James Piercy, Victoria Higgins

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 95 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 13%
Researcher 11 12%
Student > Master 6 6%
Student > Doctoral Student 5 5%
Other 4 4%
Other 16 17%
Unknown 41 43%
Readers by discipline Count As %
Medicine and Dentistry 24 25%
Pharmacology, Toxicology and Pharmaceutical Science 9 9%
Biochemistry, Genetics and Molecular Biology 5 5%
Nursing and Health Professions 5 5%
Unspecified 3 3%
Other 7 7%
Unknown 42 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 49. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2023.
All research outputs
#881,606
of 25,766,791 outputs
Outputs from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#48
of 1,196 outputs
Outputs of similar age
#17,795
of 325,524 outputs
Outputs of similar age from Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
#1
of 8 outputs
Altmetric has tracked 25,766,791 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,196 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.1. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 325,524 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them